Factors and Perceptions Affecting Treatment Choices of Breast Cancer Patients

U

University of Haifa

Status

Unknown

Conditions

Breast Cancer

Treatments

Other: Factors and perceptions questionnaire
Other: Qualitative interview

Study type

Observational

Funder types

Other

Identifiers

NCT02679638
27-15

Details and patient eligibility

About

A Multi-center Cross-sectional quantitative study with a preliminary qualitative study part aiming to identify and analyze demand factors, supply factors and perceptions affecting Breast Cancer patients' treatment choices of Breast Cancer patients in 5 key decision points: participation role in the decision making process, hospital choice, treatment regimen choice, surgical extent and surgeon choice. 25 patients and caregivers will participate in the qualitative part and 425 Israeli Breast Cancer patients will participate in the quantitative study.

Full description

Background: Breast Cancer (BC) is the most common cancer in women worldwide. Newly diagnosed BC patients are asked to participate in a number of treatment related decisions. No research has systematically studied the full decision sequence in a disease such as BC, analyzing demand factors, supply factors and patient perceptions. Study goal: Identify and analyze demand factors, supply factors and perceptions affecting BC patients' treatment choices, and model the demand function of BC patients in 5 key decision points: participation role in the decision making process, hospital choice, treatment regimen choice, surgical extent and surgeon choice. Study hypothesis: Patient perceptions will have at least as much impact as demand and supply factors. Study design: Two stage study. A preliminary qualitative study, holding depth interviews with 20 breast cancer patients, 2 spouses and 3 staff members is taking place these days. The qualitative study findings will be used to develop a survey questionnaire for a cross sectional quantitative study, interviewing a quota sample of 425 breast cancer survivors, diagnosed up to 5 years prior to joining the study, who have successfully completed all radiation therapy and chemotherapy. Data analysis: Qualitative data will be analyzed according to the Criteria Bases Qualitative Methodology. Quantitative data will be analyzed by two-variable statistical analysis and multi-variable statistical analysis adjusted to the nature of the dependent and independent variables. Possible policy recommendations: Forming consulting teams for cancer patients. Improving medical information communication. Focusing patients on the key decisions they face. Evaluating patient needs using demand factors, supply factors and perceptions to create systemic tools helping them face treatment decisions.

Enrollment

450 estimated patients

Sex

Female

Ages

30 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Hebrew speaking Jewish women
  • Aged 30 - 75 years
  • Diagnosed with breast cancer up to 5 years prior to study recruitment
  • Successfully completed all chemotherapy and radiotherapy treatments
  • Considered Cancer free

Exclusion criteria

  • Any type of residual cancer
  • Any type of chemotherapy or radiotherapy

Trial design

450 participants in 4 patient groups

Kaplan Hospital
Description:
Breast cancer survivors recruited at the Kaplan Medical Center
Treatment:
Other: Qualitative interview
Other: Factors and perceptions questionnaire
Rambam Hospital
Description:
Breast cancer survivors recruited at the Rambam Medical Center
Treatment:
Other: Qualitative interview
Other: Factors and perceptions questionnaire
Sheba
Description:
Breast cancer survivors recruited at the Sheba Medical Center
Treatment:
Other: Factors and perceptions questionnaire
Barzilai
Description:
Breast cancer survivors recruited at the Barzilai Medical Center
Treatment:
Other: Factors and perceptions questionnaire

Trial contacts and locations

0

Loading...

Central trial contact

Boaz Hovav, MD; Shuli Brammli-Greenberg, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems